Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Xenobiotic and Natural Chemicals

被引:349
作者
Rendic, Slobodan [1 ]
Guengerich, F. Peter [2 ,3 ]
机构
[1] Univ Zagreb, HR-1000 Zagreb, Croatia
[2] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA
基金
美国国家卫生研究院;
关键词
DRUG-INTERACTIONS; IN-VITRO; 46A1; INHIBITOR; BRAIN; VIVO;
D O I
10.1021/tx500444e
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Analyzing the literature resources used in our previous reports, we calculated the fractions of the oxidoreductase enzymes FMO (microsomal flavin-containing monooxygenase), AKR (aldo-keto reductase), MAO (monoamine oxidase), and cytochrome P450 participating in metabolic reactions. The calculations show that the fractions of P450s involved in metabolism of all chemicals (general chemicals, natural and physiological compounds, and drugs) are rather consistent in the findings that > 90% of enzymatic reactions are catalyzed by P450s. Regarding drug metabolism, three-fourths of the human P450 reactions can be accounted for by a set of five P450s: 1A2, 2C9, 2C19, 2D6, and 3A4, and the largest fraction of the P450 reactions is catalyzed by P450 3A enzymes. P450 3A4 participation in metabolic reactions of drugs varied from 13% for general chemicals to 27% for drugs.
引用
收藏
页码:38 / 42
页数:5
相关论文
共 12 条
[1]  
[Anonymous], ADME DATABASE WEB SE
[2]   Orphans in the Human Cytochrome P450 Superfamily: Approaches to Discovering Functions and Relevance in Pharmacology [J].
Guengerich, F. Peter ;
Cheng, Qian .
PHARMACOLOGICAL REVIEWS, 2011, 63 (03) :684-699
[3]   Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain [J].
Mast, N ;
Norcross, R ;
Andersson, U ;
Shou, MG ;
Nakayama, K ;
Bjorkhem, I ;
Pikuleva, IA .
BIOCHEMISTRY, 2003, 42 (48) :14284-14292
[4]   Pharmacologic Stimulation of Cytochrome P450 46A1 and Cerebral Cholesterol Turnover in Mice [J].
Mast, Natalia ;
Li, Yong ;
Linger, Marlin ;
Clark, Matthew ;
Wiseman, Jeffrey ;
Pikuleva, Irina A. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (06) :3529-3538
[5]   Binding of a Cyano- and Fluoro-containing Drug Bicalutamide to Cytochrome P450 46A1 UNUSUAL FEATURES AND SPECTRAL RESPONSE [J].
Mast, Natalia ;
Zheng, Wenchao ;
Stout, C. David ;
Pikuleva, Irina A. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (07) :4613-4624
[6]   Summary of information on human CYP enzymes: Human P450 metabolism data [J].
Rendic, S .
DRUG METABOLISM REVIEWS, 2002, 34 (1-2) :83-448
[7]   Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors [J].
Rendic, S ;
DiCarlo, FJ .
DRUG METABOLISM REVIEWS, 1997, 29 (1-2) :413-580
[8]   Contributions of Human Enzymes in Carcinogen Metabolism [J].
Rendic, Slobodan ;
Guengerich, F. Peter .
CHEMICAL RESEARCH IN TOXICOLOGY, 2012, 25 (07) :1316-1383
[9]   The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo [J].
Shafaati, Marjan ;
Mast, Natalia ;
Beck, Olof ;
Nayef, Rima ;
Heo, Gun Young ;
Bjorkhem-Bergman, Linda ;
Luetjohann, Dieter ;
Bjorkhem, Ingemar ;
Pikuleva, Irina A. .
JOURNAL OF LIPID RESEARCH, 2010, 51 (02) :318-323
[10]   Predicting in vivo drug interactions from in vitro drug discovery data [J].
Wienkers, LC ;
Heath, TG .
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (10) :825-833